While there are multiple alleles of NCU09544 present among these four strains, all alleles carry the same nonsense mutation and vary in the number SNPs and the sizes of indels present.
Little is known about other genetic or epigenetic factors, which can occur concurrently with BRAF and NRAS mutations, and may vary between regions, with possible prognostic implications, for example, PTEN loss is uncommon in NRAS-mutant melanoma but occurs in BRAF-mutant melanoma and can activate the PI3K pathway (Hodis et al, 2012).
However, differences in frequency and mutation type varied between species and with 4-NQO concentration (Rosenkranz and Poirier 1979).
The basic idea is although mutations are highly heterogeneous and vary from one sample to another, the processes that are disrupted when cells undergo transformation tend to be invariant across a population for a particular cancer or cancer subtype.
The frequencies of deleterious, neutral, and beneficial mutations varied slightly between the 8- and 77-task environments, but these differences were not statistically significant (F: χ2 = 2.976, 2 d.f., P = 0.226; R: χ2 = 0.080, 2 d.f., P = 0.961).
The ration of the average percentage of the abnormal Hb in heterozygotes with HBA2 (α2) and HBA1 mutations (α1) varied from 1.1 to 1.8, with a mean value of 1.3.
When only reports from studies on sporadic rather than familial colorectal cancer or colorectal cancer cell lines are considered, the mutation frequencies are lower and vary between 30 and 70% [ 17, 44- 49], and a population-based case-control study in the Netherlands reported a 32% mutation frequency [ 50].
Also in samples with 2 co-occurring mutations, the ratio of the double mutations varied in primary and lymph node tumors.
The prevalence of BRCA1 and BRCA2 mutations in Spain is heterogeneous and varies according to geographical origin of studied families.
However, the magnitude of association between time to first appearance and mutation type varied according to the Gag cleavage product in which the mutations occurred (interaction test, p = 0.008), as did the association between time to completeness and mutation type (interaction test, p = 0.02).
